Ticker Details
DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
IPO Date:	April 14, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$28.18B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.87 | 2.19%
Avg Daily Range (30 D):	$1.27 | 1.74%
Avg Daily Range (90 D):	$1.20 | 1.81%

Institutional Daily Volume
Avg Daily Volume:	2.06M
Avg Daily Volume (30 D):	3.76M
Avg Daily Volume (90 D):	3.72M

Trade Size
Avg Trade Size (Sh.):	131
Avg Trade Size (Sh.) (30 D):	59
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	21,385
Avg Institutional Trade:	$7.3M
Avg Institutional Trade (30 D):	$9.79M
Avg Institutional Trade (90 D):	$8.93M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$25.63M
Avg Closing Trade (30 D):	$84.84M
Avg Closing Trade (90 D):	$70.96M
Avg Closing Volume:	376.52K

News

Jun 18, 2026 @ 3:41 PM 3 Stocks Doing the Heavy Lifting in Healthcareââ‚... Source: Jessica Mitacek

Jun 15, 2026 @ 5:02 PM Dexcom Scores Pediatric Expansion For OTC Stelo Gl... Source: Vandana Singh

Jun 4, 2026 @ 5:53 PM [Latest] Non-Invasive Blood Glucose Monitoring Dev... Source: Zion Market Research

May 15, 2026 @ 5:41 PM Diabetes Tech Player DexCom Lays Out 2030 Growth V... Source: Vandana Singh

May 12, 2026 @ 4:04 PM Sell in May and Go Away—Starting With These... Source: Bridget Bennett

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.14	$.69	$2.14
Diluted EPS	$2.09	$.67	$2.09
Revenue	$4.66B	$1.26B	$4.66B
Gross Profit	$2.8B	$792.7M	$2.8B
Net Income / Loss	$836.3M	$267.3M	$836.3M
Operating Income / Loss	$911.8M	$323M	$911.8M
Cost of Revenue	$1.86B	$466.9M	$1.86B
Net Cash Flow	$311.8M	$-917.8M	$311.8M
PE Ratio

Splits
Jun 13, 2022	4:1